Global RNA Interference (RNAi) Drug Delivery Professional Survey Report 2022, Forecast to 2027

Code: RW00014778608
Multimarket Insight
Aug-2022
Life Sciences
108 Pages

RNA interference (RNAi) is the biologic process by which RNA molecules induce sequence-specific inhibition of target gene expression or translation. RNAi was demonstrated to occur in mammalian cells in 2001.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the RNA Interference (RNAi) Drug Delivery industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
Nanoparticle Drug Delivery Technology
Pulmonary Drug Delivery Technology
Nucleic Acid Drug Delivery Technology
Aptamer Drug Delivery Technology

Market Segment by Product Application
Infectious Diseases
Cardiology
Oncology
Neurology
Ophthalmology
Metabolic Disorders

Finally, the report provides detailed profile and data information analysis of leading company.
Metabolic disorders
RXi Pharmaceuticals Corp
Access Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Marina Biotech Inc
Merck & Co. Inc
Silence Therapeutics plc
Calondo Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Quark Pharmaceuticals Inc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global RNA Interference (RNAi) Drug Delivery consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of RNA Interference (RNAi) Drug Delivery market by identifying its various subsegments.
3.Focuses on the key global RNA Interference (RNAi) Drug Delivery manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the RNA Interference (RNAi) Drug Delivery with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of RNA Interference (RNAi) Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global RNA Interference (RNAi) Drug Delivery Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 RNA Interference (RNAi) Drug Delivery Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 RNA Interference (RNAi) Drug Delivery Segment by Type
2.1.1 Nanoparticle Drug Delivery Technology
2.1.2 Pulmonary Drug Delivery Technology
2.1.3 Nucleic Acid Drug Delivery Technology
2.1.4 Aptamer Drug Delivery Technology
2.2 Market Analysis by Application
2.2.1 Infectious Diseases
2.2.2 Cardiology
2.2.3 Oncology
2.2.4 Neurology
2.2.5 Ophthalmology
2.2.6 Metabolic Disorders
2.3 Global RNA Interference (RNAi) Drug Delivery Market Comparison by Regions (2017-2027)
2.3.1 Global RNA Interference (RNAi) Drug Delivery Market Size (2017-2027)
2.3.2 North America RNA Interference (RNAi) Drug Delivery Status and Prospect (2017-2027)
2.3.3 Europe RNA Interference (RNAi) Drug Delivery Status and Prospect (2017-2027)
2.3.4 Asia-pacific RNA Interference (RNAi) Drug Delivery Status and Prospect (2017-2027)
2.3.5 South America RNA Interference (RNAi) Drug Delivery Status and Prospect (2017-2027)
2.3.6 Middle East & Africa RNA Interference (RNAi) Drug Delivery Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): RNA Interference (RNAi) Drug Delivery Industry Impact
2.5.1 RNA Interference (RNAi) Drug Delivery Business Impact Assessment - Covid-19
2.5.2 Market Trends and RNA Interference (RNAi) Drug Delivery Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global RNA Interference (RNAi) Drug Delivery Sales and Market Share by Manufacturer (2017-2022)
3.2 Global RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global RNA Interference (RNAi) Drug Delivery Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 RNA Interference (RNAi) Drug Delivery Manufacturer Market Share
3.5 Top 10 RNA Interference (RNAi) Drug Delivery Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into RNA Interference (RNAi) Drug Delivery Market
3.7 Key Manufacturers RNA Interference (RNAi) Drug Delivery Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of RNA Interference (RNAi) Drug Delivery Industry Key Manufacturers
4.1 Metabolic disorders
4.1.1 Company Details
4.1.2 Metabolic disorders RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Metabolic disorders News
4.2 RXi Pharmaceuticals Corp
4.2.1 Company Details
4.2.2 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.2.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 RXi Pharmaceuticals Corp News
4.3 Access Pharmaceuticals Inc
4.3.1 Company Details
4.3.2 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.3.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Access Pharmaceuticals Inc News
4.4 Alnylam Pharmaceuticals Inc
4.4.1 Company Details
4.4.2 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.4.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Alnylam Pharmaceuticals Inc News
4.5 Marina Biotech Inc
4.5.1 Company Details
4.5.2 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.5.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Marina Biotech Inc News
4.6 Merck & Co. Inc
4.6.1 Company Details
4.6.2 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.6.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Merck & Co. Inc News
4.7 Silence Therapeutics plc
4.7.1 Company Details
4.7.2 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.7.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Silence Therapeutics plc News
4.8 Calondo Pharmaceuticals Inc
4.8.1 Company Details
4.8.2 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.8.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Calondo Pharmaceuticals Inc News
4.9 Dicerna Pharmaceuticals Inc
4.9.1 Company Details
4.9.2 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.9.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Dicerna Pharmaceuticals Inc News
4.10 Quark Pharmaceuticals Inc
4.10.1 Company Details
4.10.2 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.10.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Quark Pharmaceuticals Inc News
4.11 Tacere Therapeutics Inc
4.11.1 Company Details
4.11.2 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.11.3 Tacere Therapeutics Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Tacere Therapeutics Inc News
4.12 PhaseRx Inc
4.12.1 Company Details
4.12.2 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.12.3 PhaseRx Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 PhaseRx Inc News
4.13 Sirnaomics Inc
4.13.1 Company Details
4.13.2 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification
4.13.3 Sirnaomics Inc RNA Interference (RNAi) Drug Delivery Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Sirnaomics Inc News

5 Global RNA Interference (RNAi) Drug Delivery Sales Categorized by Regions
5.1 Global RNA Interference (RNAi) Drug Delivery Revenue, Sales and Market Share by Regions
5.1.1 Global RNA Interference (RNAi) Drug Delivery Sales and Market Share by Regions (2017-2022)
5.1.2 Global RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Regions (2017-2022)
5.2 North America RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
5.3 Europe RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
5.4 Asia-pacific RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
5.5 South America RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)

6 North America RNA Interference (RNAi) Drug Delivery Market Size Categorized by Countries
6.1 North America RNA Interference (RNAi) Drug Delivery Sales, Revenue and Market Share by Countries
6.1.1 North America RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
6.1.2 North America RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
6.1.3 United States RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
6.1.4 Canada RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
6.1.5 Mexico RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
6.2 North America RNA Interference (RNAi) Drug Delivery Revenue (Value) by Manufacturers
6.3 North America RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (2017-2022)
6.4 North America RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

7 Europe RNA Interference (RNAi) Drug Delivery Market Size Categorized by Countries
7.1 Europe RNA Interference (RNAi) Drug Delivery Sales, Revenue and Market Share by Countries
7.1.1 Europe RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
7.1.2 Europe RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
7.1.3 Germany RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
7.1.4 UK RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
7.1.5 France RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
7.1.6 Russia RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
7.1.7 Italy RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
7.1.8 Spain RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
7.2 Europe RNA Interference (RNAi) Drug Delivery Revenue (Value) by Manufacturers
7.3 Europe RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (2017-2022)
7.4 Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

8 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Size Categorized by Countries
8.1 Asia-pacific RNA Interference (RNAi) Drug Delivery Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
8.1.3 China RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
8.1.4 South Korea RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
8.1.5 Japan RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
8.1.6 Australia RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
8.1.7 India RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
8.2 Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue (Value) by Manufacturers
8.3 Asia-pacific RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

9 South America RNA Interference (RNAi) Drug Delivery Market Size Categorized by Countries
9.1 South America RNA Interference (RNAi) Drug Delivery Sales, Revenue and Market Share by Countries
9.1.1 South America RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
9.1.2 South America RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
9.1.3 Brazil RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
9.2 South America RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (2017-2022)
9.3 South America RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

10 Middle East and Africa RNA Interference (RNAi) Drug Delivery Market Size Categorized by Countries
10.1 Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
10.1.3 GCC Countries RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
10.1.4 Turkey RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
10.1.5 Egypt RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
10.1.6 South America RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type
10.3 Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)

11 Global RNA Interference (RNAi) Drug Delivery Market Segment by Type
11.1 Global RNA Interference (RNAi) Drug Delivery Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (2017-2022)
11.1.2 Global RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Type (2017-2022)
11.2 Nanoparticle Drug Delivery Technology Sales Growth Rate and Price
11.2.1 Global Nanoparticle Drug Delivery Technology Sales Growth Rate (2017-2022)
11.2.2 Global Nanoparticle Drug Delivery Technology Price (2017-2022)
11.3 Pulmonary Drug Delivery Technology Sales Growth Rate and Price
11.3.1 Global Pulmonary Drug Delivery Technology Sales Growth Rate (2017-2022)
11.3.2 Global Pulmonary Drug Delivery Technology Price (2017-2022)
11.4 Nucleic Acid Drug Delivery Technology Sales Growth Rate and Price
11.4.1 Global Nucleic Acid Drug Delivery Technology Sales Growth Rate (2017-2022)
11.4.2 Global Nucleic Acid Drug Delivery Technology Price (2017-2022)
11.5.1 Global Aptamer Drug Delivery Technology Sales Growth Rate (2017-2022)
11.5.2 Global Aptamer Drug Delivery Technology Price (2017-2022)

12 Global RNA Interference (RNAi) Drug Delivery Market Segment by Application
12.1 Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2017-2022)
12.2 Infectious Diseases Sales Growth Rate (2017-2022)
12.3 Cardiology Sales Growth Rate (2017-2022)
12.4 Oncology Sales Growth Rate (2017-2022)
12.5 Neurology Sales Growth Rate (2017-2022)
12.7 Metabolic Disorders Sales Growth Rate (2017-2022)

13 Global RNA Interference (RNAi) Drug Delivery Market Forecast
13.1 Global RNA Interference (RNAi) Drug Delivery Revenue, Sales and Growth Rate (2022-2027)
13.2 RNA Interference (RNAi) Drug Delivery Market Forecast by Regions (2022-2027)
13.2.1 North America RNA Interference (RNAi) Drug Delivery Market Forecast (2022-2027)
13.2.2 Europe RNA Interference (RNAi) Drug Delivery Market Forecast (2022-2027)
13.2.3 Asia-Pacific RNA Interference (RNAi) Drug Delivery Market Forecast (2022-2027)
13.2.4 South America RNA Interference (RNAi) Drug Delivery Market Forecast (2022-2027)
13.2.5 Middle East & Africa RNA Interference (RNAi) Drug Delivery Market Forecast (2022-2027)
13.3 RNA Interference (RNAi) Drug Delivery Market Forecast by Type (2022-2027)
13.3.1 Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Type (2022-2027)
13.3.2 Global RNA Interference (RNAi) Drug Delivery Market Share Forecast by Type (2022-2027)
13.4 RNA Interference (RNAi) Drug Delivery Market Forecast by Application (2022-2027)
13.4.1 Global RNA Interference (RNAi) Drug Delivery Sales Forecast by Application (2022-2027)
13.4.2 Global RNA Interference (RNAi) Drug Delivery Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 RNA Interference (RNAi) Drug Delivery Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 RNA Interference (RNAi) Drug Delivery Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture RNA Interference (RNAi) Drug Delivery
Figure Market Concentration Ratio and Market Maturity Analysis of RNA Interference (RNAi) Drug Delivery
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global RNA Interference (RNAi) Drug Delivery Market Size by Type
Figure Global Market Share of RNA Interference (RNAi) Drug Delivery by Type in 2021
Figure Nanoparticle Drug Delivery Technology Picture
Figure Pulmonary Drug Delivery Technology Picture
Figure Nucleic Acid Drug Delivery Technology Picture
Figure Aptamer Drug Delivery Technology Picture
Table Global RNA Interference (RNAi) Drug Delivery Market Size (Volume) by Application
Figure Infectious Diseases Picture
Figure Cardiology Picture
Figure Oncology Picture
Figure Neurology Picture
Figure Ophthalmology Picture
Figure Metabolic Disorders Picture
Table Global RNA Interference (RNAi) Drug Delivery Comparison by Regions (M USD) 2017-2027
Figure Global RNA Interference (RNAi) Drug Delivery Market Size (Million US$) (2017-2027)
Figure North America RNA Interference (RNAi) Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe RNA Interference (RNAi) Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure South America RNA Interference (RNAi) Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa RNA Interference (RNAi) Drug Delivery Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and RNA Interference (RNAi) Drug Delivery Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global RNA Interference (RNAi) Drug Delivery Sales by Manufacturer (2017-2022)
Figure Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Manufacturer in 2021
Table Global RNA Interference (RNAi) Drug Delivery Revenue by Manufacturer (2017-2022)
Figure Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Global RNA Interference (RNAi) Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 RNA Interference (RNAi) Drug Delivery Manufacturer (Revenue) Market Share in 2021
Figure Top 10 RNA Interference (RNAi) Drug Delivery Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into RNA Interference (RNAi) Drug Delivery Market
Table Key Manufacturers RNA Interference (RNAi) Drug Delivery Product Type
Table Mergers & Acquisitions Planning
Table Metabolic disorders Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Metabolic disorders
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Metabolic disorders 2017-2022
Table Metabolic disorders Main Business
Table Metabolic disorders Recent Development
Table RXi Pharmaceuticals Corp Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of RXi Pharmaceuticals Corp
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of RXi Pharmaceuticals Corp 2017-2022
Table RXi Pharmaceuticals Corp Main Business
Table RXi Pharmaceuticals Corp Recent Development
Table Access Pharmaceuticals Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Access Pharmaceuticals Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Access Pharmaceuticals Inc 2017-2022
Table Access Pharmaceuticals Inc Main Business
Table Access Pharmaceuticals Inc Recent Development
Table Alnylam Pharmaceuticals Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Alnylam Pharmaceuticals Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Alnylam Pharmaceuticals Inc 2017-2022
Table Alnylam Pharmaceuticals Inc Main Business
Table Alnylam Pharmaceuticals Inc Recent Development
Table Marina Biotech Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Marina Biotech Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Marina Biotech Inc 2017-2022
Table Marina Biotech Inc Main Business
Table Marina Biotech Inc Recent Development
Table Merck & Co. Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Merck & Co. Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck & Co. Inc 2017-2022
Table Merck & Co. Inc Main Business
Table Merck & Co. Inc Recent Development
Table Silence Therapeutics plc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Silence Therapeutics plc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Silence Therapeutics plc 2017-2022
Table Silence Therapeutics plc Main Business
Table Silence Therapeutics plc Recent Development
Table Calondo Pharmaceuticals Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Calondo Pharmaceuticals Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Calondo Pharmaceuticals Inc 2017-2022
Table Calondo Pharmaceuticals Inc Main Business
Table Calondo Pharmaceuticals Inc Recent Development
Table Dicerna Pharmaceuticals Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Dicerna Pharmaceuticals Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dicerna Pharmaceuticals Inc 2017-2022
Table Dicerna Pharmaceuticals Inc Main Business
Table Dicerna Pharmaceuticals Inc Recent Development
Table Quark Pharmaceuticals Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Quark Pharmaceuticals Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Quark Pharmaceuticals Inc 2017-2022
Table Quark Pharmaceuticals Inc Main Business
Table Quark Pharmaceuticals Inc Recent Development
Table Tacere Therapeutics Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Tacere Therapeutics Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Tacere Therapeutics Inc 2017-2022
Table Tacere Therapeutics Inc Main Business
Table Tacere Therapeutics Inc Recent Development
Table PhaseRx Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of PhaseRx Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of PhaseRx Inc 2017-2022
Table PhaseRx Inc Main Business
Table PhaseRx Inc Recent Development
Table Sirnaomics Inc Company Profile
Table RNA Interference (RNAi) Drug Delivery Product Introduction, Application and Specification of Sirnaomics Inc
Table RNA Interference (RNAi) Drug Delivery Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sirnaomics Inc 2017-2022
Table Sirnaomics Inc Main Business
Table Sirnaomics Inc Recent Development
Figure Global RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Global RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2017-2022)
Table Global RNA Interference (RNAi) Drug Delivery Sales by Regions (2017-2022)
Figure Global RNA Interference (RNAi) Drug Delivery Sales Market Share by Regions in 2021
Table Global RNA Interference (RNAi) Drug Delivery Revenue by Regions (2017-2022)
Figure Global RNA Interference (RNAi) Drug Delivery Revenue Market Share by Regions in 2021
Figure North America RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Europe RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Asia-pacific RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure South America RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Middle East & Africa RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure North America RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2017-2022)
Table North America RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
Table North America RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries (2017-2022)
Figure North America RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries in 2021
Table North America RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
Table North America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure North America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries in 2021
Figure United States RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Canada RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Mexico RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Table North America RNA Interference (RNAi) Drug Delivery Revenue by Manufacturer (2021)
Figure North America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Manufacturer in 2021
Table North America RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022)
Table North America RNA Interference (RNAi) Drug Delivery Sales Share by Type (2017-2022)
Table North America RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022)
Table North America RNA Interference (RNAi) Drug Delivery Sales Share by Application (2017-2022)
Figure Europe RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2017-2022)
Table Europe RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
Table Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries (2017-2022)
Figure Europe RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries in 2021
Table Europe RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
Table Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries in 2021
Figure Germany RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure UK RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure France RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Russia RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Italy RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Spain RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Table Europe RNA Interference (RNAi) Drug Delivery Revenue by Manufacturer (2021)
Figure Europe RNA Interference (RNAi) Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Europe RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022)
Table Europe RNA Interference (RNAi) Drug Delivery Sales Share by Type (2017-2022)
Table Europe RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022)
Table Europe RNA Interference (RNAi) Drug Delivery Sales Share by Application (2017-2022)
Figure Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2017-2022)
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries (2017-2022)
Figure Asia-pacific RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries in 2021
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries in 2021
Figure China RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure South Korea RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Japan RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Australia RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure India RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Figure Southeast Asia RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue by Manufacturer (2021)
Figure Asia-pacific RNA Interference (RNAi) Drug Delivery Revenue Market Share by Manufacturer in 2021
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022)
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Sales Share by Type (2017-2022)
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022)
Table Asia-pacific RNA Interference (RNAi) Drug Delivery Sales Share by Application (2017-2022)
Figure South America RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries (2017-2022)
Figure South America RNA Interference (RNAi) Drug Delivery Sales Market Share by Countries in 2019
Table South America RNA Interference (RNAi) Drug Delivery Revenue by Countries (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries (2017-2022)
Figure South America RNA Interference (RNAi) Drug Delivery Revenue Market Share by Countries in 2019
Figure Brazil RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Sales by Type (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Sales Share by Type (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Revenue by Type (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Sales by Application (2017-2022)
Table South America RNA Interference (RNAi) Drug Delivery Sales Share by Application (2017-2022)
Figure Middle East and Africa RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2017-2022)
Table Middle East and Africa RNA Interference (RNAi) Drug Delivery Sales (Volume) by Countries (20

Metabolic disorders
RXi Pharmaceuticals Corp
Access Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Marina Biotech Inc
Merck & Co. Inc
Silence Therapeutics plc
Calondo Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Quark Pharmaceuticals Inc
Tacere Therapeutics Inc
PhaseRx Inc
Sirnaomics Inc

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE